Open access
Aug 2026
Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy
Tregs engineered with an orthogonal IL-2 tethered to its receptor persisted without exogenous IL-2 and exhibited superior therapeutic efficacy in a mouse model of type 1 diabetes.
Alyssa C. Indart, Huiyun Lyu, V. Nguyen et al.
· Journal of Experimental Medi... · 0 citations